99 related articles for article (PubMed ID: 6116030)
1. Reactions to dapsone.
Lancet; 1981 Sep; 2(8246):585. PubMed ID: 6116030
[No Abstract] [Full Text] [Related]
2. Agranulocytosis associated with Maloprim.
Br Med J (Clin Res Ed); 1983 May; 286(6376):1515. PubMed ID: 6405867
[No Abstract] [Full Text] [Related]
3. Agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone).
Booth F; Barker LC; Barton CJ; Naik RB
Postgrad Med J; 1984 Aug; 60(706):566-7. PubMed ID: 6473241
[TBL] [Abstract][Full Text] [Related]
4. Maloprim--general toxicity or idiosyncrasy?
Vergara RV
P N G Med J; 1984 Mar; 27(1):46. PubMed ID: 6595907
[No Abstract] [Full Text] [Related]
5. Chemoprophylaxis of malaria in Africa.
Rée GH
Br Med J (Clin Res Ed); 1983 Feb; 286(6364):562. PubMed ID: 6402151
[No Abstract] [Full Text] [Related]
6. Agranulocytosis associated with malaria prophylaxis with Maloprim.
Friman G; Nyström-Rosander C; Jonsell G; Björkman A; Lekås G; Svendsrup B
Br Med J (Clin Res Ed); 1983 Apr; 286(6373):1244-5. PubMed ID: 6404407
[No Abstract] [Full Text] [Related]
7. Maloprim and agranulocytosis.
Bruce-Chwatt LJ; Hutchinson DB
Lancet; 1983 Dec 24-31; 2(8365-66):1487-8. PubMed ID: 6140569
[No Abstract] [Full Text] [Related]
8. Agranulocytosis associated with Maloprim.
Bruce-Chwatt LJ; Hutchinson DB
Br Med J (Clin Res Ed); 1984 Jan; 288(6410):65-6. PubMed ID: 6418319
[No Abstract] [Full Text] [Related]
9. Maloprim-induced agranulocytosis and red-cell aplasia.
Nicholls MD; Concannon AJ
Med J Aust; 1982 Dec 11-25; 2(12):564-6. PubMed ID: 7162443
[No Abstract] [Full Text] [Related]
10. Agranulocytosis associated with maloprim: review of cases.
Hutchinson DB; Whiteman PD; Farquhar JA
Hum Toxicol; 1986 Jul; 5(4):221-7. PubMed ID: 3733111
[TBL] [Abstract][Full Text] [Related]
11. Maloprim for malaria prophylaxis.
Donovan KD
Med J Aust; 1985 Sep; 143(7):319-20. PubMed ID: 4046929
[No Abstract] [Full Text] [Related]
12. Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):165-6. PubMed ID: 3081784
[No Abstract] [Full Text] [Related]
13. Malaria chemoprophylaxis--which drug?
Biddulph J
P N G Med J; 1983 Jun; 26(2):127-30. PubMed ID: 6388184
[No Abstract] [Full Text] [Related]
14. Risk of acute non-specific upper respiratory tract infections in healthy men taking dapsone-pyrimethamine for prophylaxis against malaria.
Lee PS; Lau EY
Br Med J (Clin Res Ed); 1988 Mar; 296(6626):893-5. PubMed ID: 3129063
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary toxicity of malaria prophylaxis.
Davidson AC; Bateman C; Shovlin C; Marrinan M; Burton GH; Cameron IR
BMJ; 1988 Nov; 297(6658):1240-1. PubMed ID: 3145065
[No Abstract] [Full Text] [Related]
16. Haemoglobinuria after a single dose treatment with dapsone and pyrimethamine for falciparum malaria in a patient with glucose-6-phosphate dehydrogenase deficiency.
Ponnampalam JT
Trop Geogr Med; 1981 Dec; 33(4):401-2. PubMed ID: 7342390
[No Abstract] [Full Text] [Related]
17. Severe dapsone syndrome due to weekly maloprim.
Grayson ML; Yung AP; Doherty RR
Lancet; 1988 Mar; 1(8584):531. PubMed ID: 2893942
[No Abstract] [Full Text] [Related]
18. Red cell hypoplasia following dapsone and pyrimethamine.
Gelfand M; Froese EH
Cent Afr J Med; 1983 Sep; 29(9):181-3. PubMed ID: 6640649
[No Abstract] [Full Text] [Related]
19. Haematological safety of long-term malarial prophylaxis with dapsone-pyrimethamine.
Cook IF; Kish MY
Med J Aust; 1985 Aug; 143(4):139-41. PubMed ID: 4021907
[TBL] [Abstract][Full Text] [Related]
20. Fixed drug eruptions to maloprim.
Tham SN; Chan HL
Singapore Med J; 1988 Jun; 29(3):300-2. PubMed ID: 2973126
[No Abstract] [Full Text] [Related]
[Next] [New Search]
